In the tumor microenvironment, abnormally activated TGF-β signaling makes T cells into Tregs, inhibiting natural killer (NK) cells from killing tumor cells and promoting immunosuppressive effect (65, 66). This evidence concerns the gene TGFB1 and neoplasm.